BDBM13643 3-Oxybenzamide 29::3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}-4-(trifluoromethyl)benzamide

SMILES FC(F)(F)c1ccc(cc1OCCc1ccc(Cl)cc1Cl)C(=O)NCC1CCN(CC1)c1ccncc1

InChI Key InChIKey=IVCLCGPMDAQQDD-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 13643   

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13643(3-Oxybenzamide 29 | 3-[2-(2,4-dichlorophenyl)ethox...)
Affinity DataKi:  140nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13643(3-Oxybenzamide 29 | 3-[2-(2,4-dichlorophenyl)ethox...)
Affinity DataKi:  140nMAssay Description:Inhibitory activity against human Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetProthrombin(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13643(3-Oxybenzamide 29 | 3-[2-(2,4-dichlorophenyl)ethox...)
Affinity DataKi:  3.18E+4nMAssay Description:The inhibitory effect of test compound for human thrombin was determined by using the chromogenic substrates S-2366. The hydrolysis rates of chromoge...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed